Stock Price
616.80
Daily Change
3.00 0.49%
Monthly
-13.15%
Yearly
10.10%
Q1 Forecast
598.33

argenx SE reported $5.83B in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
AstraZeneca USD 28.72B 1.22B Dec/2025
Galapagos EUR 3.08B 82.56M Dec/2025
Genmab DKK 3.91B 127M Jun/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GRIFOLS EUR 5.07B 274.77M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Qiagen NV USD 2B 535.87M Dec/2025
UCB EUR 4.79B 1.47B Dec/2024